Engineering Diptheria Toxin towards the Development of Therapeutics against Breast Cancer
Abstract
We have completed the crystal structure determination of diphtheria toxin bound to its normal receptor (Louie et al., Molecular Cell, 1, 67-78, 1997). The crystal structure of diphtheria toxin (DT) complexed 1:1 with a extracellular fragment of its cell-surface receptor. The toxin receptor is a membrane-bound precursor of a heparin-binding EGF-like growth factor (HB-EGF). The structure reveals that a sheet in the receptor-binding domain of DT packs against a (beta)-sheet of the EGF-like fold. Using a three-dimensional picture as a guide, we have identified key atoms dictating the fit between toxin and receptor and remodify the toxin to target to heregulin, whose overexpression is correlated with the onset of metastatic breast cancer. Future studies will include testing the function of this recombinant toxin in cell culture systems of breast cancer cell lines.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 1999
- Accession Number
- ADA386220
Entities
People
- Senyon Choe
Organizations
- Salk Institute for Biological Studies